Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |